title: Inflammatory responses to influenza vaccination at the extremes of age.
abstract: Age affects the immune response to vaccination, with individuals at the extremes of age responding poorly. The initial inflammatory response to antigenic materials shapes the subsequent adaptive response and so understanding is required about the effect of age on the profile of acute inflammatory mediators. In this study we measured the local and systemic inflammatory response after influenza vaccination or infection in neonatal, young adult and aged mice. Mice were immunized intramuscularly with inactivated influenza vaccine with and without the adjuvant MF59 and then challenged with H1N1 influenza. Age was the major factor affecting the inflammatory profile after vaccination: neonatal mice had more interleukin-1α (IL-1α), C-reactive protein (CRP) and granulocyte-macrophage colony-stimulating factor (GMCSF), young adults more tumour necrosis factor-α (TNF), and elderly mice more interleukin-1 receptor antagonist (IL-1RA), IL-2RA and interferon-γ-induced protein 10 (IP10). Notably the addition of MF59 induced IL-5, granulocyte colony-stimulating factor (G-CSF), Keratinocyte Chemotractant (KC) and monocyte chemoattractant protein 1 (MCP1) in all ages of animals and levels of these cytokines correlated with antibody responses. Age also had an impact on the efficacy of vaccination: neonatal and young adult mice were protected against challenge, but aged mice were not. There were striking differences in the localization of the cytokine response depending on the route of exposure: vaccination led to a high serum response whereas intranasal infection led to a low serum response but a high lung response. In conclusion, we demonstrate that age affects the inflammatory response to both influenza vaccination and infection. These age-induced differences need to be considered when developing vaccination strategies for different age groups.
authors.affiliation: Mucosal Infection and Immunity group, Section of Virology, Department of Medicine, Imperial College London, London, UK.
authors.forename: Jacqueline U
authors.initials: JU
authors.lastname: McDonald
authors.affiliation: Mucosal Infection and Immunity group, Section of Virology, Department of Medicine, Imperial College London, London, UK.
authors.forename: Ziyun
authors.initials: Z
authors.lastname: Zhong
authors.affiliation: Mucosal Infection and Immunity group, Section of Virology, Department of Medicine, Imperial College London, London, UK.
authors.forename: Helen T
authors.initials: HT
authors.lastname: Groves
authors.affiliation: Mucosal Infection and Immunity group, Section of Virology, Department of Medicine, Imperial College London, London, UK.
authors.forename: John S
authors.identifier: 0000-0001-8093-8741
authors.initials: JS
authors.lastname: Tregoning
mesh_terms: D000375:Aging / Q000276:immunology*; D000818:Animals; D000831:Animals, Newborn; D000914:Antibodies, Viral / Q000097:blood; D016207:Cytokines / Q000378:metabolism; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology*; D007252:Influenza Vaccines / Q000276:immunology*; D007251:Influenza, Human / Q000276:immunology*; D008168:Lung / Q000276:immunology* / Q000821:virology; D051379:Mice; D009976:Orthomyxoviridae Infections / Q000276:immunology*; D011136:Polysorbates / Q000008:administration & dosage; D013185:Squalene / Q000008:administration & dosage; D014611:Vaccination
chemical_list: D000914:Antibodies, Viral; D016207:Cytokines; D018836:Inflammation Mediators; D007252:Influenza Vaccines; C089950:MF59 oil emulsion; D011136:Polysorbates; D013185:Squalene
keywords: cytokine; lung; mucosa; vaccination; viral